Sixteen studies only monitored individuals over a period of 24 to 54 weeks. Only 1 study, which compared insulin detemir and human insulin in adults, lasted 24 months. Human insulin often not used in the best possible way In addition, IQWiG discovered that the procedure schemes differed in the individual studies. Specifically, the frequency of the insulin shots varied. It was notable that patients received specifications particularly on the use of long-acting human insulin, which prevented them from injecting this type of insulin in a genuine way that is customary and recommended in Germany. Studies were therefore mainly considered in the benefit assessment where individuals were allowed to separately optimize their treatment with individual insulin.Diabetes, which affects 26.8 million people in the U.S., is characterized by your body’s inability to correctly regulate levels of blood glucose, or blood sugar. Insulin, a hormone produced by the pancreas, normally regulates the body’s glucose levels, but in people who have diabetes insufficient degrees of insulin are created or the body does not react adequately to the insulin it creates. Historically, mealtime insulin therapy regimens experienced several limitations, including the threat of severe hypoglycemia, the probability of excess weight gain, inadequate post-meal glucose control, the necessity for complicated titration of insulin doses regarding the meals and the necessity for injections.